• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . Prevalence of symptoms associated with Long COVID among adolescents in the United States, Summer 2022

tetano

Editor, Senior Moderator
J Infect Dis


. 2025 Aug 30:jiaf454.
doi: 10.1093/infdis/jiaf454. Online ahead of print. Prevalence of symptoms associated with Long COVID among adolescents in the United States, Summer 2022

Deja L Edwards[SUP] 1 2 [/SUP], Leora R Feldstein[SUP] 2 [/SUP], Alexandra F Dalton[SUP] 2 [/SUP], Nicole D Ford[SUP] 2 [/SUP], Sharon H Saydah[SUP] 2 [/SUP]



Affiliations
Abstract

Purpose: Limited information is known about Long COVID among adolescents. This study will compare the risks associated with symptoms among adolescents who tested positive, were tested but never tested positive, and who were never tested for SARS-CoV-2 infection.
Methods: Porter Novelli survey data were collected from adolescents (12-17 years) from May 31 - July 6, 2022. Respondents self-reported their SARS-CoV-2 test results and were classified accordingly by test status. Wald's chi-squared tests were used to determine whether demographic factors and characteristics related to symptoms differed by test status. Multivariable logistic regression models were used to estimate the odds of reporting (1) symptoms lasting four weeks or longer and (2) symptoms lasting three or more months by test status and SARS-CoV-2 variant period.
Results: Data were collected from 784 respondents: 264 (34%) tested positive, 291 (37%) never tested positive, and 229 (29%) were never tested for SARS-CoV-2 infection. At least one symptom lasting four weeks or longer were reported by 41% of the positive respondents, compared to 12% of negative respondents and 11% of never tested respondents (p<0.05). The odds of reporting at least one symptom lasting four or more weeks did not vary by SARS-CoV-2 variant period. Adolescents who tested positive had increased odds of any neurological symptom lasting three or more months compared to negative adolescents.
Discussion: Our results demonstrate adolescents who tested positive for SARS-CoV-2 were more likely to report at least one symptom lasting for at least four weeks. However, most of these symptoms appeared to have resolved within three months.

Keywords: COVID-19; Long COVID; Post-COVID Conditions; SARS-CoV-2; adolescents.

 
Back
Top